Methamidophos

DB14972ExperimentalSmall molecule

Methamidophos is under investigation in clinical trial NCT03223753 (Web-Based Physical Activity Intervention in Improving Long Term Health in Children and Adolescents With Newly Diagnosed Acute Lymphoblastic Leukemia in First Remission).

Mechanism: Pharmacologically active on Acetylcholinesterase and Cholinesterase
Curator reviewed
Formula / weight: C₂H₈NO₂PS · 141.129 g/mol (avg)
Also known as: MONITOR

Resolves to

Compound

UNII8Z083FM94WCAS10265-92-6ChEMBLCHEMBL504888ChEBI38721KEGGC18667

Structure

InChIKeyNNKVPIKMPCQWCG-UHFFFAOYSA-NSMILESCOP(N)(=O)SC

Targets

P22303ACHEP06276BCHEQ8IY17PNPLA6

What you can answer from here — as of July 07, 2026

3Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

6+ReferencesStructured and connected to the statements they support

Which drugs share a target with Methamidophos, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account